title: What can we say to women of reproductive age with epilepsy?
authors.forename: Patricia
authors.initials: P
authors.lastname: Penovich
authors.forename: Eija
authors.initials: E
authors.lastname: Gaily
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology* / Q000517:prevention & control; D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D009421:Nervous System Malformations / Q000139:chemically induced / Q000453:epidemiology; D010353:Patient Education as Topic / Q000592:standards; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology / Q000517:prevention & control; D011297:Prenatal Exposure Delayed Effects / Q000453:epidemiology* / Q000517:prevention & control; D018570:Risk Assessment; D013226:Status Epilepticus / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D014227:Triazines / Q000008:administration & dosage / Q000009:adverse effects; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000927:Anticonvulsants; D014227:Triazines; D014635:Valproic Acid; D000077213:Lamotrigine